Polydatin: A natural compound with multifaceted anticancer properties.

Cancer poses a significant global health challenge, contributing to substantial mortality rates and driving the urgent need for exploration into bioactive compounds with potent anticancer properties. Polydatin (PD), a stilbenoid compound abundant in various fruits and vegetables, has emerged as a promising candidate in cancer research. Renowned in traditional Chinese medicine for its multifaceted biological activities encompassing antioxidant, anti-inflammatory, anticancer, hepatoprotective, neuroprotective, and immunostimulatory effects, PD stands out as a versatile therapeutic agent. This review paper meticulously compiles the diverse anticancer attributes of polydatin across a spectrum of cancer types, elucidating its impact on pivotal cancer hallmarks such as proliferation, migration, metastasis, apoptosis, modulation of the tumour microenvironment, autophagy, and more. Furthermore, the review intricately explores the intricate pathways influenced by polydatin within cancer cells, unveiling its mechanisms of action and identifying potential therapeutic targets. By providing a comprehensive analysis of how polydatin affects various facets of cancer progression and addresses treatment resistance, this paper aims to enhance our understanding of its pivotal role in cancer therapy. Moreover, the synergistic potential of polydatin in combination with other drugs is investigated to underscore its amplified efficacy in combating cancer through innovative mechanism-based strategies. The synthesis of these insights underscores polydatin's significance as a valuable component in the advancement of novel approaches to cancer prevention and treatment. Goals: This review aims to comprehensively compile and analyze the diverse anticancer attributes of polydatin (PD) across various cancer types, elucidating its impact on pivotal cancer hallmarks such as proliferation, migration, metastasis, apoptosis, and modulation of the tumour microenvironment. Additionally, it explores the intricate pathways influenced by polydatin within cancer cells, unveiling its mechanisms of action and identifying potential therapeutic targets. Moreover, the review investigates polydatin's potential synergistic effects with other anticancer drugs, while also examining its therapeutic and preventive effects against various cancers. Methods: A systematic review of scientific literature, comprising research articles, clinical trials, and reviews, was conducted to analyze polydatin's anticancer properties. Reputable databases like PubMed, ScienceDirect, and Google Scholar were searched, and selected studies were critically evaluated to extract essential insights into polydatin's mechanisms of action and its interactions with other anticancer drugs, utilizing keywords targeting specific cancer types such as colorectal, oral, breast, and cervical cancer. Findings: The review and additional online research on polydatin reveal that it exhibits multifaceted biological activities, including antioxidant, anti-inflammatory, and anticancer effects. Across various cancer types, polydatin demonstrates promising properties, impacting key cancer hallmarks such as proliferation and metastasis. These findings underscore polydatin's diverse therapeutic potential, particularly in cancer treatment, by targeting crucial pathways involved in cancer progression and offering insights into its mechanisms of action. Results: Polydatin shows potential as a valuable component in cancer therapy, addressing various facets of cancer progression and treatment resistance.Synergistic potential with other drugs suggests amplified efficacy in combating cancer through innovative mechanism-based strategies.The review underscores the significance of polydatin in the advancement of novel approaches for cancer prevention and treatment.